Company: PMVP
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001193125-25-276000
Chunk: 1

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

  Exhibit      Description                                                                       Form      File No.      Number      Filing Date  
                                                                                                                                                  
   Number                                                                                                                                         
     99.1      Press Release issued by PMV Pharmaceuticals, Inc., dated November 12, 2025.                                                        
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                       

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                               PMV Pharmaceuticals, Inc.                                                    
  Date: November 12, 2025      By:                            /s/ Michael Carulli                           
                                                              Michael Carulli                               
                                                              Chief Financial Officer